Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study

Affiliations

• ¹ Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
• ² St. Jude Children's Research Hospital, Memphis, TN, USA.
• ³ Children's Hospital Boston, Boston, MA, USA.
• ⁴ Brigham and Women's Hospital, Boston, MA, USA.
• ⁵ University of California, San Francisco, San Francisco, CA, USA.
• ⁶ Children's National Health System, Washington, DC, USA.
• ⁷ Pittsburgh Children's Hospital, Pittsburgh, PA, USA.
• ⁸ Stanford University, Palo Alto, CA, USA.
• ⁹ Children's Hospital Los Angeles, Los Angeles, CA, USA.
• ¹⁰ Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
• ¹¹ Duke University Medical Center, Durham, NC, USA.
• ¹² Greenbaum Cancer Center, Baltimore, MD, USA.
• ¹³ Cancer Therapy Evaluation Program, National Cancer Institute, Washington, DC, USA.
• ¹⁴ Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
• ¹⁵ Memorial Sloan Kettering Cancer Center, New York, NY, USA.